Restricted left atrial dilatation can visually differentiate cardiac amyloidosis from hypertrophic cardiomyopathy

Haruhiko Higashi1, Katsuji Inoue1, Shinji Inaba1

  • 1Department of Cardiology, Pulmonology, Hypertension and Nephrology, Ehime University Graduate School of Medicine, Toon, Japan.

ESC Heart Failure
|May 27, 2021
PubMed

Insights

Visual assessment of left atrial (LA) dilatation can help differentiate cardiac amyloidosis (CA) from hypertrophic cardiomyopathy (HCM). Restricted LA dilatation is a key indicator for CA diagnosis, aiding in early detection and risk stratification.

Area of Science:

  • Cardiology
  • Cardiovascular Imaging
  • Cardiac Electrophysiology

Background:

  • Cardiac amyloidosis (CA) and hypertrophic cardiomyopathy (HCM) are distinct infiltrative and genetic myocardial diseases, respectively.
  • CA can present with clinical and echocardiographic features that mimic HCM, complicating diagnosis.
  • Accurate differentiation is crucial for appropriate patient management and prognosis.

Purpose of the Study:

  • To evaluate the diagnostic capability of visual assessment of left atrial (LA) function, specifically LA dilatation, in differentiating CA from HCM using echocardiography.
  • To compare the discriminatory power of visual LA dilatation grading with quantitative LA function parameters.

Main Methods:

  • Retrospective analysis of 127 patients (93 with HCM, 34 with CA) with cardiac magnetic resonance imaging or biopsy confirmation.
  • Echocardiographic assessment of LA dilatation grade (preserved=1, abnormal=2, restricted=3) based on reservoir phase expansion.
  • Reproducibility of visual LA dilatation grading assessed using kappa statistics.
  • Quantitative evaluation of LA emptying fraction and reservoir strain.
  • Kaplan-Meier analysis to assess cardiac event rates based on LA dilatation grade.

Main Results:

  • Visual LA dilatation grading demonstrated good intra- and inter-observer reproducibility (kappa=0.82 and 0.70).
  • Restricted LA dilatation (Grade 3) was more prevalent in CA (71%) compared to HCM.
  • Patients with CA showed significantly higher LA dilatation grades than those with HCM (P<0.01).
  • The area under the curve for differentiating CA and HCM was highest for LA dilatation grade (0.88) and LA emptying fraction (0.88).
  • Restricted LA dilatation was associated with a higher incidence of cardiac events (P<0.01).

Conclusions:

  • Visual assessment of LA dilatation, particularly restricted LA dilatation, is a valuable tool for diagnosing CA.
  • Echocardiographic evaluation of LA function can aid in differentiating CA from HCM.
  • This method may help identify high-risk patients with HCM and those with CA requiring further investigation.
Abstract

Related Concept Videos

Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
113
Cardiomyopathy I: Introduction and Classification01:25

Cardiomyopathy I: Introduction and Classification

Cardiomyopathy, or CMP, is a group of diseases affecting the myocardial structure, impairing its ability to pump blood effectively. This condition can lead to arrhythmias, heart failure, or sudden cardiac death.Cardiomyopathies are classified into primary and secondary categories:Primary Cardiomyopathy refers to conditions involving only the heart muscle that are often idiopathic (of unknown cause) or genetic. They primarily affect the myocardium without the involvement of other systemic...
176
Cardiomyopathy II: Dilated Cardiomyopathy01:30

Cardiomyopathy II: Dilated Cardiomyopathy

Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
114
Cardiomyopathy IV: Restrictive Cardiomyopathy01:29

Cardiomyopathy IV: Restrictive Cardiomyopathy

Restrictive cardiomyopathy (RCM) is a rare heart muscle disease characterized by impaired ventricular filling due to stiffened ventricular walls, leading to significant diastolic dysfunction.EtiologyRestrictive cardiomyopathy can arise from both inherited and acquired diseases, many of which are systemic. It is categorized into four main types: infiltrative, storage, non-infiltrative, and endomyocardial diseases.Infiltrative diseases, such as amyloidosis, lead to RCM by depositing amyloid...
149
Aortic Regurgitation II: Clinical Features and Diagnostic Tests01:22

Aortic Regurgitation II: Clinical Features and Diagnostic Tests

Aortic valve regurgitation (AR) occurs when the aortic valve fails to close properly, allowing blood to flow backward from the aorta into the left ventricle. This backflow can result in two distinct clinical presentations: acute and chronic AR, each characterized by its own set of symptoms and physical findings.Acute Aortic RegurgitationAcute AR presents with a sudden onset of severe symptoms. Patients typically experience profound dyspnea (shortness of breath), chest pain, and signs of left...
146
Mitral Stenosis II: Clinical features and Diagnostic Tests01:23

Mitral Stenosis II: Clinical features and Diagnostic Tests

Mitral stenosis is a heart condition in which the mitral valve, which allows blood to flow from the left atrium to the left ventricle, becomes narrowed or stenotic. This narrowing hinders blood flow and leads to clinical symptoms requiring specific medical evaluations and management strategies. The following overview outlines the clinical symptoms, assessments, diagnostic findings, prevention methods, and treatments for mitral stenosis.Clinical ManifestationsDyspnea (shortness of breath): This...
62